By João Luis D’Orey Facco Vianna
August 9, 2017
Overview of Medicinal product regulation and product liability in Brazil
The Q&A gives a high level overview of key issues including pricing and state funding, manufacturing, marketing, clinical trials, advertising, labelling, and product recall and liability.
The Q&A is part of the global guide to life sciences law. For a full list of jurisdictional Q&As visit www.practicallaw.com/lifesciences-guide.
Share:
Last by João Luis D’Orey Facco Vianna
April 15, 2020
The Brazilian PTO establishes prioritization of technologies associated with the treatment and diagnosis of Covid-19
By means of publication made in the Official Gazette 2,570, dated April 7th, 2020, the Brazilian Patent Office promulgated Ordinance No. 149/2020, … The Brazilian PTO establishes prioritization of technologies associated with the treatment and diagnosis of Covid-19
October 25, 2019
BPTO publishes new rules to request participation on Patent Prosecution Highway (PPH) programs
The Brazilian Patent and Trademark Office (BPTO) published Resolution 225/19 which institutes rulings on the pilot project for the Patent Prosecution Highway … BPTO publishes new rules to request participation on Patent Prosecution Highway (PPH) programs
August 12, 2019
Pharmaceutical IP and competition law in Brazil: 2019
A Q&A guide to pharmaceutical IP and competition law in Brazil. The Q&A gives a high level overview of key issues including … Pharmaceutical IP and competition law in Brazil: 2019